Pfizer Says It Will Pay $784M To Resolve Protonix Medicaid Rebate False Claims

(February 16, 2016, 2:15 PM EST) -- NEW YORK — Pfizer Inc. on Feb. 16 announced that its Wyeth subsidiary has reached an agreement in principle to resolve federal allegations about the calculation of Medicaid rebates for its Protonix heartburn drug for $784.6 million.

A spokesperson for the U.S. Attorney’s Office for the District of Massachusetts told Mealey Publications that a tentative settlement has been reached but declined to comment further.

Pfizer says the agreement covers claims about improper rebate calculations between 2001 and 2006. It added that the rebate activity took place...
To view the full article, register now.